About this trial
Preterm Premature Rupture of Membranes (PPROM) before 37 weeks of pregnancy is responsible for 40% of preterm births in the United States. The PPROM Registry aims to identify possible causes of PPROM, evaluate trends in expectant management, measure maternal and fetal care, and to review short term and long term outcomes of affected pregnancies and births.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Women diagnosed with Preterm Premature Rupture of Membranes (PPROM) prior to 37 weeks of pregnancy
Disqualifiers
Those without a clinical diagnosis or confirmation of PPROM in pregnancy
Diagnosis of PROM beyond 37 weeks of pregnancy
Trial population
Women diagnosed with Preterm Premature Rupture of Membranes (PPROM) prior to 37 weeks of pregnancy
Trial design
Ecologic or community
Other
Treatments tested in this trial
There is no intervention associated with this study.
Other interventionThere is no intervention associated with this study.
Treatment groups
Trial outcomes
Primary outcomes
Early Neonatal Mortality Rate
Secondary outcomes
Stillbirth / Perinatal Mortality Rate
Other outcomes
Review of Socio-Economic Factors in pProm
Sponsors and contacts
Click on the lead sponsor to view all of their trials.